JP2023172954A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023172954A5 JP2023172954A5 JP2023084942A JP2023084942A JP2023172954A5 JP 2023172954 A5 JP2023172954 A5 JP 2023172954A5 JP 2023084942 A JP2023084942 A JP 2023084942A JP 2023084942 A JP2023084942 A JP 2023084942A JP 2023172954 A5 JP2023172954 A5 JP 2023172954A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- oligonucleotide molecule
- consisting solely
- oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22382493 | 2022-05-23 | ||
| EP22382493.9A EP4282964A1 (en) | 2022-05-23 | 2022-05-23 | Oligonucleotides conjugated to oleic acid and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023172954A JP2023172954A (ja) | 2023-12-06 |
| JP2023172954A5 true JP2023172954A5 (enExample) | 2025-01-28 |
| JP7663873B2 JP7663873B2 (ja) | 2025-04-17 |
Family
ID=81941129
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024569113A Pending JP2025522282A (ja) | 2022-05-23 | 2023-05-23 | オレイン酸にコンジュゲートしたオリゴヌクレオチド及びその使用 |
| JP2023084942A Active JP7663873B2 (ja) | 2022-05-23 | 2023-05-23 | オレイン酸にコンジュゲートしたオリゴヌクレオチド及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024569113A Pending JP2025522282A (ja) | 2022-05-23 | 2023-05-23 | オレイン酸にコンジュゲートしたオリゴヌクレオチド及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12116575B2 (enExample) |
| EP (3) | EP4282964A1 (enExample) |
| JP (2) | JP2025522282A (enExample) |
| CN (1) | CN119816594A (enExample) |
| AU (1) | AU2023277730A1 (enExample) |
| CA (1) | CA3255781A1 (enExample) |
| IL (1) | IL317141A (enExample) |
| TW (1) | TW202411424A (enExample) |
| WO (1) | WO2023227622A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4282964A1 (en) * | 2022-05-23 | 2023-11-29 | Universitat de Valéncia | Oligonucleotides conjugated to oleic acid and uses thereof |
| WO2025114442A1 (en) * | 2023-11-28 | 2025-06-05 | Arthex Biotech S.L. | Oligonucleotides conjugated to oleic acid and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1648914A4 (en) * | 2003-07-31 | 2009-12-16 | Regulus Therapeutics Inc | OLIGOMERIC COMPOUNDS AND COMPOSITIONS USEFUL FOR MODULATING SMALL NON-CODING RNA |
| CA2889044A1 (en) * | 2012-11-15 | 2014-05-22 | Roche Innovation Center Copenhagen A/S | Anti apob antisense conjugate compounds |
| EP3169776B1 (en) * | 2014-07-14 | 2025-09-03 | The Regents of The University of California | Crispr/cas transcriptional modulation |
| WO2016201272A1 (en) * | 2015-06-12 | 2016-12-15 | King Abdulaziz City For Science And Technology | Method of diagnosing patients with conditions caused by mendelian mutations |
| NZ781029A (en) * | 2015-10-09 | 2025-07-25 | Wave Life Sciences Ltd | Oligonucleotide compositions and methods thereof |
| ES2659845B1 (es) | 2016-09-19 | 2019-01-04 | Univ Valencia | Modulación de microRNAs contra la distrofia miotónica tipo 1 y antagonistas de microRNAs para ello |
| JP2021531278A (ja) * | 2018-07-20 | 2021-11-18 | レグルス セラピューティクス インコーポレイテッド | オリゴヌクレオチドの経口送達のための方法 |
| US12037585B2 (en) | 2019-12-23 | 2024-07-16 | University Of Massachusetts | Oligonucleotides for tissue specific gene expression modulation |
| EP4282964A1 (en) * | 2022-05-23 | 2023-11-29 | Universitat de Valéncia | Oligonucleotides conjugated to oleic acid and uses thereof |
-
2022
- 2022-05-23 EP EP22382493.9A patent/EP4282964A1/en not_active Withdrawn
-
2023
- 2023-05-23 CA CA3255781A patent/CA3255781A1/en active Pending
- 2023-05-23 EP EP23174951.6A patent/EP4282966A1/en active Pending
- 2023-05-23 AU AU2023277730A patent/AU2023277730A1/en active Pending
- 2023-05-23 IL IL317141A patent/IL317141A/en unknown
- 2023-05-23 JP JP2024569113A patent/JP2025522282A/ja active Pending
- 2023-05-23 EP EP23724333.2A patent/EP4486891A1/en active Pending
- 2023-05-23 US US18/322,487 patent/US12116575B2/en active Active
- 2023-05-23 CN CN202380056273.5A patent/CN119816594A/zh active Pending
- 2023-05-23 WO PCT/EP2023/063829 patent/WO2023227622A1/en not_active Ceased
- 2023-05-23 JP JP2023084942A patent/JP7663873B2/ja active Active
- 2023-05-23 TW TW112119205A patent/TW202411424A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023172954A5 (enExample) | ||
| US8431543B2 (en) | Chitosan based polymer conjugate and a method for producing the same | |
| KR102142180B1 (ko) | 세포에 핵산을 도입하기 위한 조성물 | |
| JP2023123491A5 (enExample) | ||
| JP2013525330A5 (enExample) | ||
| JP2025032110A5 (enExample) | ||
| JP2005500025A5 (enExample) | ||
| JP2009517048A5 (enExample) | ||
| JP2006502694A5 (enExample) | ||
| JP2020526192A (ja) | アルファ−ＥＮａＣの発現を阻害するためのＲＮＡｉ剤、および使用方法 | |
| US20240417422A1 (en) | Arnatar compounds and methods for enhanced cellular uptake | |
| CN115521220A (zh) | 长链烷基酯胺类化合物及其制备方法和在核酸递送方面的应用 | |
| US20130079383A1 (en) | Lipid Compounds Targeting VLA-4 | |
| IL317141A (en) | Oleic acid-conjugated oligonucleotides and uses thereof | |
| CN115996729A (zh) | 用于个人医疗保健应用的适配体 | |
| CN118436605A (zh) | 一种肺选择性脂质组合物及其构建方法和应用 | |
| EP2569328B1 (en) | Programmable self-assembled nanostructures based on sidechain-modified pna for the multivalent display of ligands | |
| US20250376684A1 (en) | Threose nucleic acid antisense oligonucleotides and methods thereof | |
| CN115960901B (zh) | 一种用于抗病毒的磷酰胺吗啉代反义寡核苷酸及其应用 | |
| US20220340904A1 (en) | Method for the production of a catalytically active DNA molecule having improved activity and its use in a method of treating asthma | |
| Campbell et al. | Synthesis of a new disulfide Fmoc monomer for creating biologically susceptible linkages in peptide nucleic acid oligomers | |
| US20190367920A1 (en) | Antisense oligonucleotides for modulating nfkb1 expression | |
| CN115702006B (zh) | 缀合基团及其缀合物 | |
| JPWO2021113851A5 (enExample) | ||
| CN118512601A (zh) | 双链核酸-半乳糖胺-胆固醇化合物及其应用 |